SERPINA1 is a new frontier in cancer immunotherapy and drug targeting by pan-cancer analysis
Crossref DOI link: https://doi.org/10.1007/s12672-025-02832-5
Published Online: 2025-06-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fu, Chen
Hu, Yanyun
Yang, Lei
Sun, Weifeng
Text and Data Mining valid from 2025-06-08
Version of Record valid from 2025-06-08
Article History
Received: 4 March 2025
Accepted: 27 May 2025
First Online: 8 June 2025
Declarations
:
: All authors approved this manuscript for publication.
: The authors declare no competing interests.